NLRP6 and colitis: The absence of NLRP6 in experimental colitis results in a greater susceptibility to the development of the disease, determining the impairment of the intestinal microbiota, severe intestinal inflammation, and the inability to restore epithelial barrier integrity [43,45,46,86].